3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
Pemetrexed
8
Spinal Puncture
5
Specimen Handling
4
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
aflutinib
3
Trastuzumab
3
Bevacizumab
3
trastuzumab deruxtecan
2
pembrolizumab
2
osimertinib
2
Radiotherapy, Intensity-Modulated
2
tucatinib
1
toripalimab
1
sintilimab
1
sacituzumab govitecan
1
pertuzumab
1
peginterferon alfa-2b
1
lorlatinib
1
lenvatinib
1
azeliragon
1
avelumab
1
adavosertib
1
Temozolomide
1
Referral and Consultation
1
Radiosurgery
1
Radiation
1
Probability
1
Physical Examination
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningeal Carcinomatosis
×
tipifarnib
×
1 year
×
Clear all
No trials found.